INIS
eyes
100%
patients
91%
optics
43%
thickness
35%
surgery
34%
mitomycin
33%
clinical trials
29%
valves
29%
nerves
23%
comparative evaluations
22%
control
22%
reduction
19%
layers
19%
injection
18%
ischemia
16%
closures
16%
values
16%
management
16%
populations
16%
congenital diseases
15%
fibers
14%
depth
14%
cornea
14%
failures
13%
steroids
13%
correlations
12%
losses
12%
length
11%
implants
11%
tomography
11%
erythropoietin
10%
cataracts
9%
biometrics
9%
evaluation
8%
iran
8%
diseases
8%
devices
8%
refractories
8%
lenses
8%
vessels
8%
reviews
8%
methanol
7%
grafts
7%
mutations
7%
vision
7%
data
7%
design
7%
surveys
7%
applications
7%
risks
6%
Medicine and Dentistry
Intraocular Pressure
37%
Patient
30%
Glaucoma
29%
Glaucoma Valve
24%
Trabeculectomy
23%
Randomized Clinical Trial
22%
Mitomycin
18%
Therapeutic Procedure
14%
Biometry
14%
Follow up
14%
Anterior Chamber of Eyeball
13%
Open Angle Glaucoma
11%
Best Corrected Visual Acuity
11%
Arteritic Anterior Ischemic Optic Neuropathy
10%
Complication
9%
Surgery
8%
Retinal Nerve Fiber Layer
8%
Age
7%
Glaucoma Medication
7%
Visual Acuity
7%
Pseudoexfoliation
6%
Congenital Glaucoma
6%
Prevalence
6%
Neovascular Glaucoma
6%
Iridotomy
5%
Injection
5%
Subtenon Drug Administration
5%
Drug Therapy
5%
Free Tissue Graft
5%
Corneal Dystrophy
5%
Radial Keratotomy
5%
Erythropoietin
5%
Fasudil
5%
Cornea
5%
Keyphrases
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
7%
Primary Congenital Glaucoma
7%
Intraocular Pressure
7%
Glaucoma Patients
5%
Methanol-induced Optic Neuropathy
5%
Granular Corneal Dystrophy
5%
Radial Keratotomy
5%
Recent-onset
5%
CYP1B1 mutations
5%
Neovascular Glaucoma
5%
Ahmed Glaucoma Valve Implantation
5%
Aphakic Glaucoma
5%